Compositions, methods and systems for polymerase chain reaction assays
US-9822393-B2 · Nov 21, 2017 · US
US10676778B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10676778-B2 |
| Application number | US-201715818601-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 20, 2017 |
| Priority date | Mar 8, 2013 |
| Publication date | Jun 9, 2020 |
| Grant date | Jun 9, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods, devices, systems and compositions for detecting nucleic acids in polymerase chain reaction assays, such as droplet digital polymerase chain reaction (ddPCR) assays, using intercalating dyes. A dual surfactant system with at least one fluorosurfactant and at least one non-ionic non-fluorosurfactant may be employed for droplet generation and nucleic acid detection.
Opening claim text (preview).
We claim: 1. A composition, comprising: a continuous phase including an oil and a fluorosurfactant mixture, wherein said fluorosurfactant mixture includes a triblock copolymer comprising a first polyethylene glycol (PEG) block covalently linked to a respective polyhexafluoropropylene oxide (PFPE) block at each end of the first PEG block, a diblock copolymer comprising a second PEG block covalently linked to a PFPE block at only one end of the second PEG block, and a PFPE carboxylic acid; and aqueous droplets suspended in the continuous phase and comprising nucleic acid, a non-ionic non-fluorosurfactant, and an intercalating dye; wherein the first PEG block and each respective PFPE block of the triblock copolymer are linked to one another by an ester bond, and wherein the second PEG block and the PFPE block of the diblock copolymer are linked to one another by an ester bond. 2. The composition of claim 1 , wherein the triblock copolymer has the formula wherein each of m 1 and m 2 is a number from about 10 to 100, and wherein n is a number from about 15 to 30. 3. The composition of claim 2 , wherein each of m 1 and m 2 is a number from about 20 to 40, and wherein n is a number from about 10 to 60. 4. The composition of claim 2 , wherein the diblock copolymer has the formula wherein m 3 is a number from about 20 to 50, wherein n 2 is a number from about 8 to 30, and wherein R is H or an alkyl group. 5. The composition of claim 4 , wherein the PFPE carboxylic acid has the formula wherein n is about 15 to 50. 6. The composition of claim 2 , wherein the PFPE carboxylic acid has the formula wherein n is about 15 to 50. 7. The composition of claim 1 , wherein the diblock copolymer has the formula wherein m 3 is a number from about 20 to 50, wherein n 2 is a number from about 8 to 30, and wherein R is H or an alkyl group. 8. The composition of claim 7 , wherein the PFPE carboxylic acid has the formula wherein n is about 15 to 50. 9. The composition of claim 1 , wherein the PFPE carboxylic acid has the formula wherein n is about 15 to 50. 10. The composition of claim 1 , wherein the non-ionic non-fluorosurfactant is a copolymer of ethylene oxide and propylene oxide. 11. The composition of claim 10 , wherein the non-ionic non-fluorosurfactant is a triblock copolymer of polyethylene oxide-polypropylene oxide-polyethylene oxide. 12. The composition of claim 11 , wherein the non-ionic non-fluorosurfactant is Pluronic®. 13. The composition of claim 12 , wherein the concentration of the Pluronic® is in a range from about 0.1%-3.0% (weight percent). 14. The composition of claim 1 , wherein the oil comprises a fluorous oil. 15. The composition of claim 14 , wherein the fluorous oil is 2-trifluoromethyl-3-ethoxydodeca-fluorohexane (HFE-7500) or 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)pentane (HFE-7300). 16. The composition of claim 1 , wherein the intercalating dye includes EvaGreen® dye. 17. The composition of claim 1 , wherein the nucleic acid includes a target nucleic acid, and wherein only a subset of the droplets include a copy of the target nucleic acid. 18. The composition of claim 17 , wherein the aqueous droplets further comprise primers for amplification of the target nucleic acid. 19. The composition of claim 17 , wherein the aqueous droplets further comprise a thermostable polymerase. 20. The composition of claim 19 , wherein the aqueous droplets are configured to amplify the target nucleic acid when thermally cycled.
Nucleic acid analysis using immunogens (immunoassay G01N33/53) · CPC title
Nucleic acid amplification reactions · CPC title
Specific component of sample, medium or buffer · CPC title
Quantitative amplification · CPC title
Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.